Category,Field_Name,Chinese_Name,Data_Type,Unit,Valid_Range,LOINC_Code,Required,Description,Clinical_Significance
Basic_Info,patient_id,患者ID,string,,,,,Y,唯一标识,患者追踪
Basic_Info,diagnosis_date,诊断日期,date,,,,,Y,确诊时间,疾病起点
Basic_Info,age,年龄,integer,years,18-120,,,Y,患者年龄,预后因素
Basic_Info,gender,性别,categorical,,Male,Female,,,Y,性别,流行病学
Risk_Factors,smoking_history,吸烟史,categorical,,Never,Former,Current,,,N,从不/戒烟/现吸,危险因素
Risk_Factors,diabetes_history,糖尿病史,categorical,,None,Longstanding,New_Onset,,,N,无/既往/新发,新发糖尿病提示胰腺癌
Risk_Factors,chronic_pancreatitis,慢性胰腺炎,boolean,,,,,N,慢性胰腺炎史,癌前病变
Risk_Factors,family_history,家族史,categorical,,None,Pancreatic_Cancer,Other_Cancer,Hereditary_Syndrome,,,N,无/胰腺癌/其他癌/遗传综合征,遗传风险
Histology,histologic_type,组织学类型,categorical,,Ductal_Adenocarcinoma,Acinar_Cell,Neuroendocrine,Cystic_Neoplasm,Other,,,Y,导管腺癌/腺泡细胞癌/神经内分泌肿瘤/囊性肿瘤/其他,PDAC占90%
Histology,differentiation,分化程度,categorical,,Well,Moderate,Poor,Undifferentiated,,,N,高/中/低/未分化,预后因素
Tumor_Location,tumor_site,肿瘤部位,categorical,,Head,Uncinate,Body,Tail,Diffuse,,,Y,头部/钩突/体部/尾部/弥漫,解剖位置
Tumor_Location,tumor_size,肿瘤大小,decimal,cm,0-20,33878-0,,Y,最大径,分期因素
TNM_Staging,clinical_t,临床T分期,categorical,,T1,T2,T3,T4,,,Y,T1≤2cm/T2>2-4cm/T3>4cm/T4侵犯腹腔动脉或肠系膜上动脉,可切除性关键
TNM_Staging,clinical_n,临床N分期,categorical,,N0,N1,N2,,,Y,N0无/N1:1-3个/N2:≥4个,区域淋巴结
TNM_Staging,clinical_m,临床M分期,categorical,,M0,M1,,,Y,M0无/M1有远处转移,远处转移
TNM_Staging,tnm_stage,TNM总分期,categorical,,IA,IB,IIA,IIB,III,IV,,,Y,AJCC 8th,预后分层
Resectability,resectability_status,可切除性,categorical,,Resectable,Borderline_Resectable,Locally_Advanced,Metastatic,,,Y,可切除/交界可切除/局部晚期/转移性,治疗决策核心
Resectability,vascular_involvement,血管受累,categorical,,None,Venous_Contact,Arterial_Contact,Venous_Occlusion,Arterial_Encasement,,,N,无/静脉接触/动脉接触/静脉阻塞/动脉包绕,NCCN可切除性标准
Performance,ecog_ps,ECOG体能状态,integer,,0-5,89247-1,,Y,0-5分,治疗耐受性
Labs,ca199,糖类抗原199,decimal,U/mL,0-100000,24108-7,,Y,CA19-9,诊断监测预后
Labs,cea,癌胚抗原,decimal,ng/mL,0-1000,2039-6,,N,CEA,辅助标志物
Labs,total_bilirubin,总胆红素,decimal,μmol/L,0-500,1975-2,,Y,TBIL,梗阻性黄疸
Labs,alkaline_phosphatase,碱性磷酸酶,decimal,U/L,0-1000,6768-6,,N,ALP,胆汁淤积
Labs,albumin,白蛋白,decimal,g/L,0-100,1751-7,,Y,ALB,营养状态
Imaging,ct_findings,CT表现,string,,,,,Y,胰腺肿块/血管关系,可切除性评估
Imaging,mri_findings,MRI表现,string,,,,,N,软组织分辨率,血管和肝转移
Imaging,pet_ct,PET-CT,categorical,,Not_Done,Negative,Positive,,,N,未做/阴性/阳性,远处转移筛查
Diagnosis,biopsy_method,活检方式,categorical,,EUS_FNA,CT_Guided,Surgical,None,,,N,超声内镜细针/CT引导/手术/无,病理确诊
Diagnosis,biliary_drainage,胆道引流,categorical,,None,ERCP_Stent,PTBD,,,N,无/ERCP支架/PTCD,黄疸处理
Treatment_Surgery,surgical_procedure,手术方式,categorical,,None,Whipple,Distal_Pancreatectomy,Total_Pancreatectomy,,,N,无/Whipple/胰体尾切除/全胰切除,根治性手术
Treatment_Surgery,surgical_margins,切缘状态,categorical,,R0,R1,R2,,,N,阴性/镜下阳性/肉眼阳性,R0切除预后相对好
Treatment_Surgery,lymph_nodes_examined,淋巴结检查数,integer,,0-100,,,N,病理检查淋巴结数,≥15个准确分期
Treatment_Surgery,lymph_nodes_positive,阳性淋巴结数,integer,,0-100,,,N,转移淋巴结数,预后因素
Treatment_Perioperative,neoadjuvant_therapy,新辅助治疗,categorical,,None,FOLFIRINOX,Gemcitabine_Based,Chemoradiation,,,N,无/FOLFIRINOX/吉西他滨为基础/放化疗,交界可切除标准治疗
Treatment_Perioperative,adjuvant_chemotherapy,辅助化疗,categorical,,None,Gemcitabine,mFOLFIRINOX,Gemcitabine_Capecitabine,,,N,无/吉西他滨/改良FOLFIRINOX/吉西他滨+卡培他滨,术后标准治疗6个月
Treatment_Advanced,first_line_chemotherapy,一线化疗,categorical,,None,FOLFIRINOX,Gemcitabine_Nab_Paclitaxel,Gemcitabine_Monotherapy,,,N,无/FOLFIRINOX/吉西他滨+白蛋白紫杉醇/吉西他滨单药,晚期一线
Treatment_Advanced,second_line_chemotherapy,二线化疗,categorical,,None,5FU_Liposomal_Irinotecan,FOLFIRINOX,Gemcitabine,,,N,无/5-FU+脂质体伊立替康/FOLFIRINOX/吉西他滨,疾病进展后
Treatment_Targeted,targeted_therapy,靶向治疗,categorical,,None,Erlotinib,Olaparib,,,N,无/厄洛替尼/奥拉帕利,EGFR抑制剂/PARP抑制剂(BRCA突变)
Treatment_Immunotherapy,immunotherapy,免疫治疗,categorical,,None,Pembrolizumab,,,N,无/帕博利珠单抗,MSI-H/dMMR
Molecular,brca_mutation,BRCA突变,categorical,,Not_Tested,Negative,BRCA1,BRCA2,,,N,未检测/阴性/BRCA1突变/BRCA2突变,PARP抑制剂和铂类敏感
Molecular,msi_status,微卫星不稳定性,categorical,,Not_Tested,MSS,MSI_H,,,N,未检测/稳定/高度不稳定,免疫治疗预测
Response,treatment_response,治疗反应,categorical,,Complete_Response,Partial_Response,Stable_Disease,Progressive_Disease,,,N,完全缓解/部分缓解/疾病稳定/疾病进展,RECIST标准
Complications,postoperative_pancreatic_fistula,术后胰瘘,categorical,,None,Grade_A,Grade_B,Grade_C,,,N,无/A级生化瘘/B级临床瘘/C级严重瘘,ISGPF分级
Complications,delayed_gastric_emptying,胃排空延迟,categorical,,None,Grade_A,Grade_B,Grade_C,,,N,无/A级/B级/C级,ISGPS分级
Follow_Up,ca199_response,CA19-9反应,categorical,,Normalized,Decreased,Increased,,,N,正常化/下降/升高,治疗反应监测
Follow_Up,progression_free_survival,无进展生存期,integer,months,0-200,,,N,PFS,疗效指标
Follow_Up,overall_survival,总生存期,integer,months,0-200,,,N,OS,预后指标中位OS约6-11个月
Report,oncologist,肿瘤科医师,string,,,,,Y,主管医师,责任医师
Report,report_date,报告日期,date,,,,,Y,报告时间,文档记录
